24 May 2013
Keywords: fda, approves, b-ms, orencia, jia, drug, major
Article | 14 April 2008
US drug major Bristol-Myers Squibb says that the Food and Drug Administration has approved Orencia (abatacept) for reducing signs and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 April 2008
7 April 2008
23 May 2013
© 2013 thepharmaletter.com